{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T21:04:05Z","timestamp":1789679045331,"version":"4.0.1"},"reference-count":137,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Aspects of Medicine"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.mam.2023.101218","type":"journal-article","created":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T16:59:38Z","timestamp":1700067578000},"page":"101218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Gene therapies and gene product-based drug candidates for normalizing and preserving tissue functions in animal models of ocular hypertension and glaucoma"],"prefix":"10.1016","volume":"94","author":[{"given":"Najam A.","family":"Sharif","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mam.2023.101218_bib1","article-title":"Normal and glaucomatous outflow regulation","volume":"11","author":"Acott","year":"2020","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.mam.2023.101218_bib2","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddad083","article-title":"Rare protective variants and glaucoma-relevant cell stressors modulate angiopoietin-like 7 expression","author":"Aboobakar","year":"2023","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mam.2023.101218_bib3","doi-asserted-by":"crossref","first-page":"5497","DOI":"10.1167\/iovs.14-14519","article-title":"Differential effects of caveolin-1 and -2 knockdown on aqueous outflow and altered extracellular matrix turnover in caveolin-silenced trabecular meshwork cells","volume":"55","author":"Aga","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"15","key":"10.1016\/j.mam.2023.101218_bib4","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1056\/NEJM199804093381503","article-title":"Clinical features associated with mutations in the chromosome 1 open-angle glaucoma gene (GLC1A)","volume":"338","author":"Alward","year":"1998","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.mam.2023.101218_bib5","doi-asserted-by":"crossref","first-page":"104","DOI":"10.2174\/1566523221666210423084233","article-title":"Gene therapy in the anterior eye segment","volume":"22","author":"Amador","year":"2022","journal-title":"Curr. Gene Ther."},{"issue":"1","key":"10.1016\/j.mam.2023.101218_bib6","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.preteyeres.2010.09.002","article-title":"Use of calcium channel blockers for glaucoma","volume":"30","author":"Araie","year":"2011","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.mam.2023.101218_bib7","first-page":"1","article-title":"Association of ABCA1 (rs2472493) and GAS7 (rs9913911) gene variants with primary open-angle glaucoma in a Brazilian population","volume":"28","author":"Araki","year":"2022","journal-title":"Mol. Vis."},{"key":"10.1016\/j.mam.2023.101218_bib8","doi-asserted-by":"crossref","DOI":"10.1089\/jop.2023.0006","article-title":"Ocular treatments targeting separate prostaglandin receptors in mice exhibit alterations in intraocular pressure and optic nerve lipidome","author":"Arcuri","year":"2023","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"key":"10.1016\/j.mam.2023.101218_bib9","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.3390\/genes13061055","article-title":"Bioinformatic prioritization and functional annotation of GWAS-based candidate genes for primary open-angle glaucoma","volume":"13","author":"Asefa","year":"2022","journal-title":"Genes"},{"issue":"4","key":"10.1016\/j.mam.2023.101218_bib10","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/APO.0000000000000229","article-title":"Glaucoma genetics: recent advances and future directions","volume":"5","author":"Aung","year":"2016","journal-title":"Asia Pac J. Ophthalmol."},{"issue":"1","key":"10.1016\/j.mam.2023.101218_bib11","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s00439-001-0645-7","article-title":"A major marker for normal tension glaucoma: association with polymorphisms in the OPA1 gene","volume":"110","author":"Aung","year":"2002","journal-title":"Hum. Genet."},{"issue":"4","key":"10.1016\/j.mam.2023.101218_bib12","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1167\/iovs.04-1163","article-title":"Molecular analysis of the myocilin gene in Chinese subjects with chronic primary-angle closure glaucoma","volume":"46","author":"Aung","year":"2005","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"Suppl. 1","key":"10.1016\/j.mam.2023.101218_bib13","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1097\/IJG.0000000000000928","article-title":"Genetics of exfoliation syndrome","volume":"27","author":"Aung","year":"2018","journal-title":"J. Glaucoma"},{"issue":"2","key":"10.1016\/j.mam.2023.101218_bib14","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/ng.3482","article-title":"Genome-wide association analysis identifies TXNRD2, ATXN2 and FOXC1 as susceptibility loci for primary open-angle glaucoma","volume":"48","author":"Bailey","year":"2016","journal-title":"Nat. Genet."},{"issue":"3","key":"10.1016\/j.mam.2023.101218_bib15","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/mt.2009.278","article-title":"Prostaglandin pathway gene therapy for sustained reduction of intraocular pressure","volume":"18","author":"Barraza","year":"2010","journal-title":"Mol. Ther."},{"issue":"3\u20134","key":"10.1016\/j.mam.2023.101218_bib16","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41434-020-00200-2","article-title":"Sensitization of ON-bipolar cells with ambient light activatable multi-characteristic opsin rescues vision in mice","volume":"28","author":"Batabyal","year":"2021","journal-title":"Gene Ther."},{"issue":"15","key":"10.1016\/j.mam.2023.101218_bib17","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1093\/hmg\/ddz075","article-title":"The protective variant rs7173049 at LOXL1 locus impacts on retinoic acid signaling pathway in pseudoexfoliation syndrome","volume":"28","author":"Berner","year":"2019","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/j.mam.2023.101218_bib18","first-page":"80","article-title":"The pathway from genes to gene therapy in glaucoma: a review of possibilities for using genes as glaucoma drugs","volume":"6","author":"Borr\u00e1s","year":"2017","journal-title":"Asia Pac J. Ophthalmol."},{"key":"10.1016\/j.mam.2023.101218_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2021.100975","article-title":"Early and late-stage gene therapy interventions for inherited retinal degenerations","volume":"86","author":"Botto","year":"2022","journal-title":"Prog. Retin. Eye Res."},{"issue":"7","key":"10.1016\/j.mam.2023.101218_bib20","doi-asserted-by":"crossref","first-page":"978","DOI":"10.2174\/1570159X15666170915142727","article-title":"Novel therapeutics in glaucoma management","volume":"16","author":"Bucolo","year":"2018","journal-title":"Curr. Neuropharmacol."},{"issue":"6","key":"10.1016\/j.mam.2023.101218_bib21","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/ng.824","article-title":"Genome-wide association study identifies susceptibility loci for open angle glaucoma at TMCO1 and CDKN2B-AS1","volume":"43","author":"Burdon","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.mam.2023.101218_bib22","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1167\/iovs.12-9483i","article-title":"The cell and molecular biology of glaucoma: axonopathy and the brain","volume":"53","author":"Calkins","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.mam.2023.101218_bib23","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1038\/s41598-020-80954-2","article-title":"MLIP genotype as a predictor of pharmacological response in primary open-angle glaucoma and ocular hypertension","volume":"11","author":"Canut","year":"2021","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.mam.2023.101218_bib24","doi-asserted-by":"crossref","first-page":"112","DOI":"10.12998\/wjcc.v3.i2.112","article-title":"Review and update on the molecular basis of Leber congenital amaurosis","volume":"3","author":"Chacon-Camacho","year":"2015","journal-title":"World J. Clin. Cases"},{"issue":"10","key":"10.1016\/j.mam.2023.101218_bib25","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1167\/iovs.61.10.37","article-title":"Association of glaucoma risk genes with retinal nerve fiber layer in a multi-ethnic Asian population: the Singapore epidemiology of eye diseases study","volume":"61","author":"Chai","year":"2020","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"10","key":"10.1016\/j.mam.2023.101218_bib26","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1038\/ng.3078","article-title":"Common variants near ABCA1 and in PMM2 are associated with primary open-angle glaucoma","volume":"46","author":"Chen","year":"2014","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.mam.2023.101218_bib27","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1038\/s41467-017-00837-5","article-title":"NEIGHBORHOOD consortium; International Glaucoma Genetics consortium, et al. Systems genetics identifies a role for Cacna2d1 regulation in elevated intraocular pressure and glaucoma susceptibility","volume":"8","author":"Chintalapudi","year":"2017","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.mam.2023.101218_bib28","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1038\/s41467-017-01913-6","article-title":"A large multi-ethnic genome-wide association study identifies novel genetic loci for intraocular pressure","volume":"8","author":"Choquet","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mam.2023.101218_bib29","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.preteyeres.2017.02.001","article-title":"Characterizing the \"POAGome\": a bioinformatics-driven approach to primary open-angle glaucoma","volume":"58","author":"Danford","year":"2017","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.mam.2023.101218_bib30","article-title":"Engineered mechanosensitive channel as outflow actuator for gene agnostic gene therapy of glaucoma","author":"Dibas","year":"2023","journal-title":"ARVO"},{"issue":"8","key":"10.1016\/j.mam.2023.101218_bib31","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/s41419-021-04068-x","article-title":"BCLXL gene therapy moderates neuropathology in the DBA\/2J mouse model of inherited glaucoma","volume":"12","author":"Donahue","year":"2021","journal-title":"Cell Death Dis."},{"issue":"6","key":"10.1016\/j.mam.2023.101218_bib32","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1167\/iovs.17-23223","article-title":"FOXC1 Regulates Expression of prostaglandin receptors leading to an attenuated response to latanoprost","volume":"59","author":"Doucette","year":"2018","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"6","key":"10.1016\/j.mam.2023.101218_bib33","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1167\/iovs.09-4920","article-title":"Treatment of sheep steroid-induced ocular hypertension with a glucocorticoid-inducible MMP1 gene therapy virus","volume":"51","author":"Gerometta","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.mam.2023.101218_bib34","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/s41467-020-20851-4","article-title":"Genome-wide meta-analysis identifies 127 open-angle glaucoma loci with consistent effect across ancestries","volume":"12","author":"Gharahkhani","year":"2021","journal-title":"Nat. Commun."},{"issue":"27","key":"10.1016\/j.mam.2023.101218_bib35","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2301279120","article-title":"Synthetic molecular motor activates drug delivery from polymersomes","volume":"120","author":"Guinart","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mam.2023.101218_bib36","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1167\/iovs.04-0832","article-title":"Retinal ganglion cell apoptosis in glaucoma is related to intraocular pressure and IOP-induced effects on extracellular matrix","volume":"46","author":"Guo","year":"2005","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"14","key":"10.1016\/j.mam.2023.101218_bib37","doi-asserted-by":"crossref","first-page":"7271","DOI":"10.3390\/ijms22147271","article-title":"The role of autophagy in chemical proteasome inhibition model of retinal degeneration","volume":"22","author":"Gunawan","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mam.2023.101218_bib38","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.exer.2006.09.013","article-title":"Chronic ocular hypertension induces dendrite pathology in the lateral geniculate nucleus of the brain","volume":"84","author":"Gupta","year":"2007","journal-title":"Exp. Eye Res."},{"issue":"4","key":"10.1016\/j.mam.2023.101218_bib39","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41419-022-04836-3","article-title":"Age-related visual impairments and retinal ganglion cells axonal degeneration in a mouse model harboring OPTN (E50K) mutation","volume":"13","author":"Hou","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.mam.2023.101218_bib40","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.nbd.2014.07.016","article-title":"Combinatorial targeting of early pathways profoundly inhibits neurodegeneration in a mouse model of glaucoma","volume":"71","author":"Howell","year":"2014","journal-title":"Neurobiol. Dis."},{"issue":"5","key":"10.1016\/j.mam.2023.101218_bib41","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1167\/iovs.61.5.33","article-title":"ABCA1 regulates IOP by modulating cav1\/eNOS\/NO signaling pathway","volume":"61","author":"Hu","year":"2020","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"5","key":"10.1016\/j.mam.2023.101218_bib42","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1167\/iovs.61.5.33","article-title":"ABCA1 regulates IOP by modulating Cav1\/eNOS\/NO signaling pathway","volume":"61","author":"Hu","year":"2020","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"4","key":"10.1016\/j.mam.2023.101218_bib43","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1021\/acschembio.7b01083","article-title":"Trifunctional high-throughput screen identifies promising scaffold to inhibit Grp94 and treat myocilin-associated glaucoma","volume":"13","author":"Huard","year":"2018","journal-title":"ACS Chem. Biol."},{"issue":"7","key":"10.1016\/j.mam.2023.101218_bib44","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1111\/ceo.13818","article-title":"Improvement in inner retinal function in glaucoma with nicotinamide (vitamin B3) supplementation: a crossover randomized clinical trial","volume":"48","author":"Hui","year":"2020","journal-title":"Clin. Exp. Ophthalmol."},{"issue":"10","key":"10.1016\/j.mam.2023.101218_bib45","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/ng.3087","article-title":"Genome-wide analysis of multi-ancestry cohorts identifies new loci influencing intraocular pressure and susceptibility to glaucoma","volume":"46","author":"Hysi","year":"2014","journal-title":"Nat. Genet."},{"issue":"12","key":"10.1016\/j.mam.2023.101218_bib46","doi-asserted-by":"crossref","first-page":"13728","DOI":"10.1021\/acsnano.9b07214","article-title":"Once daily pregabalin eye drops for management of glaucoma","volume":"13","author":"Ibrahim","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.mam.2023.101218_bib47","first-page":"623","article-title":"Alterations in proteome of human sclera associated with primary open-angle glaucoma involve proteins participating in regulation of the extracellular matrix","volume":"26","author":"Iomdina","year":"2020","journal-title":"Mol. Vis."},{"key":"10.1016\/j.mam.2023.101218_bib48","doi-asserted-by":"crossref","first-page":"11199","DOI":"10.1073\/pnas.1706193114","article-title":"CRISPR-Cas9\u2013based treatment of myocilin associated glaucoma","volume":"114","author":"Jain","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"22","key":"10.1016\/j.mam.2023.101218_bib49","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212508","article-title":"Astragaloside IV attenuates ocular hypertension in a mouse model of TGF\u03b22 induced primary open angle glaucoma","volume":"22","author":"Kasetti","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.mam.2023.101218_bib50","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/s41588-018-0126-8","article-title":"Genome-wide analyses identify 68 new loci associated with intraocular pressure and improve risk prediction for primary open-angle glaucoma","volume":"50","author":"Khawaja","year":"2018","journal-title":"Nat. Genet."},{"issue":"5","key":"10.1016\/j.mam.2023.101218_bib51","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/ng.3540","article-title":"Genome-wide association study identifies five new susceptibility loci for primary angle closure glaucoma","volume":"48","author":"Khor","year":"2016","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.mam.2023.101218_bib52","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3344\/kjp.2021.34.1.4","article-title":"Mirogabalin: could it be the next generation gabapentin or pregabalin?","volume":"34","author":"Kim","year":"2021","journal-title":"Korean J. Pain"},{"key":"10.1016\/j.mam.2023.101218_bib53","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/bph.14327","article-title":"Discovery, characterization and clinical utility of prostaglandin agonists for treatment of glaucoma","volume":"176","author":"Klimko","year":"2019","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.mam.2023.101218_bib54","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1167\/iovs.63.2.5","article-title":"Neuroprotective gene therapy by overexpression of the transcription factor MAX in rat models of glaucomatous neurodegeneration","volume":"63","author":"Lani-Louzada","year":"2022","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"20","key":"10.1016\/j.mam.2023.101218_bib55","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1093\/hmg\/ddx292","article-title":"Primary angle closure glaucoma (PACG) susceptibility gene PLEKHA7 encodes a novel Rac1\/Cdc42 GAP that modulates cell migration and blood-aqueous barrier function","volume":"26","author":"Lee","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mam.2023.101218_bib56","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/archopht.121.1.48","article-title":"Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial","volume":"121","author":"Leske","year":"2003","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.mam.2023.101218_bib57","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.964197","article-title":"Neuroprotection in neurodegenerations of the brain and eye: lessons from the past and directions for the future","volume":"13","author":"Levin","year":"2022","journal-title":"Front. Neurol."},{"issue":"14","key":"10.1016\/j.mam.2023.101218_bib58","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1167\/iovs.61.14.12","article-title":"A small molecule inhibitor of VE-PTP activates Tie2 in Schlemm's canal increasing outflow facility and reducing intraocular pressure","volume":"61","author":"Li","year":"2020","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"9","key":"10.1016\/j.mam.2023.101218_bib59","doi-asserted-by":"crossref","first-page":"887","DOI":"10.3390\/ph14090887","article-title":"In silico screening and in vivo evaluation of potential CACNA2D1 antagonists as intraocular pressure-reducing agents in glaucoma therapy","volume":"14","author":"Li","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.mam.2023.101218_bib60","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3389\/fncel.2018.00347","article-title":"Reduced annexin A1 secretion by ABCA1 causes retinal inflammation and ganglion cell apoptosis in a murine glaucoma model","volume":"12","author":"Li","year":"2018","journal-title":"Front. Cell. Neurosci."},{"issue":"1","key":"10.1016\/j.mam.2023.101218_bib61","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/aos.14154","article-title":"Comprehensive bioinformatics analysis of trabecular meshwork gene expression data to unravel the molecular pathogenesis of primary open-angle glaucoma","volume":"98","author":"Liesenborghs","year":"2020","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.mam.2023.101218_bib62","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.exer.2017.05.002","article-title":"Major review: molecular genetics of primary open-angle glaucoma","volume":"160","author":"Liu","year":"2017","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.mam.2023.101218_bib63","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.optom.2017.08.002","article-title":"Beta2 adrenergic receptor silencing change intraocular pressure in New Zealand rabbits","volume":"11","author":"Loma","year":"2018","journal-title":"J. Optometry"},{"key":"10.1016\/j.mam.2023.101218_bib64","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1167\/iovs.18-26489","article-title":"Association of polymorphisms at the SIX1-SIX6 locus with primary open-angle glaucoma","volume":"60","author":"Lu","year":"2019","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.mam.2023.101218_bib65","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.omtm.2021.01.012","article-title":"Ad- and AAV8-mediated ABCA1 gene therapy in a murine model with retinal ischemia\/reperfusion injuries","volume":"20","author":"Luo","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.mam.2023.101218_bib66","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.omtm.2021.01.012","article-title":"Ad- and AAV8-mediated ABCA1 gene therapy in a murine model with retinal ischemia\/reperfusion injuries","volume":"20","author":"Luo","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"issue":"10","key":"10.1016\/j.mam.2023.101218_bib67","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.ophtha.2021.03.031","article-title":"Durability of voretigene neparvovec for biallelic RPE65-mediated inherited retinal disease: phase 3 results at 3 and 4 years","volume":"128","author":"Maguire","year":"2021","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.mam.2023.101218_bib68","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13024-020-00400-9","article-title":"CNS axonal degeneration and transport deficits at the optic nerve head precede structural and functional loss of retinal ganglion cells in a mouse model of glaucoma","volume":"15","author":"Maddineni","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.mam.2023.101218_bib69","doi-asserted-by":"crossref","first-page":"204","DOI":"10.4103\/2008-322X.183914","article-title":"Update on normal tension glaucoma","volume":"11","author":"Mallick","year":"2016","journal-title":"J. Ophthalmic Vis. Res."},{"issue":"1","key":"10.1016\/j.mam.2023.101218_bib70","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/mt.2013.216","article-title":"In vitro and in vivo efficacy of SYL040012, a novel siRNA compound for treatment of glaucoma","volume":"22","author":"Mart\u00ednez","year":"2014","journal-title":"Mol. Ther."},{"issue":"18","key":"10.1016\/j.mam.2023.101218_bib71","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221810095","article-title":"Sodium 4-phenylbutyrate reduces ocular hypertension by degrading extracellular matrix deposition via activation of MMP9","volume":"22","author":"Maddineni","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"17","key":"10.1016\/j.mam.2023.101218_bib72","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1093\/hmg\/ddt210","article-title":"Enhanced optineurin E50K-TBK1 interaction evokes protein insolubility and initiates familial primary open-angle glaucoma","volume":"22","author":"Minegishi","year":"2013","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/j.mam.2023.101218_bib73","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/mt.2013.217","article-title":"Phase I clinical trial of SYL040012, a small interfering RNA targeting \u03b2-adrenergic receptor 2, for lowering intraocular pressure","volume":"22","author":"Moreno-Monta\u00f1\u00e9s","year":"2014","journal-title":"Mol. Ther."},{"issue":"8","key":"10.1016\/j.mam.2023.101218_bib74","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1167\/tvst.11.8.10","article-title":"Using advanced bioinformatics tools to identify novel therapeutic candidates for age-related macular degeneration","volume":"11","author":"Nadeem","year":"2022","journal-title":"Transl. Vis. Sci. Technol."},{"issue":"3","key":"10.1016\/j.mam.2023.101218_bib75","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/13543784.2021.1879791","article-title":"Faricimab: an investigational agent targeting the Tie-2\/angiopoietin pathway and VEGF-A for the treatment of retinal diseases","volume":"30","author":"Nicol\u00f2","year":"2021","journal-title":"Expet Opin. Invest. Drugs"},{"issue":"7","key":"10.1016\/j.mam.2023.101218_bib76","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1093\/hmg\/ddx028","article-title":"Therapeutic potential of AAV-mediated MMP-3 secretion from corneal endothelium in treating glaucoma","volume":"26","author":"O'Callaghan","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mam.2023.101218_bib77","article-title":"Matrix metalloproteinase-3 (MMP-3)\u2013mediated gene therapy for glaucoma","volume":"9","author":"O'Callaghan","year":"2023","journal-title":"Sci. Adv."},{"issue":"10","key":"10.1016\/j.mam.2023.101218_bib78","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/s41419-018-1041-8","article-title":"Neuroprotection of retinal ganglion cells by a novel gene therapy construct that achieves sustained enhancement of brain-derived neurotrophic factor\/tropomyosin-related kinase receptor-B signaling","volume":"9","author":"Osborne","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.mam.2023.101218_bib79","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.preteyeres.2018.02.002","article-title":"Neuroprotective strategies for retinal disease","volume":"65","author":"Pardue","year":"2018","journal-title":"Prog. Retin. Eye Res."},{"issue":"11","key":"10.1016\/j.mam.2023.101218_bib80","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0188899","article-title":"First-in-human phase I study of ISTH0036, an antisense oligonucleotide selectively targeting transforming growth factor beta 2 (TGF-\u03b22), in subjects with open-angle glaucoma undergoing glaucoma filtration surgery","volume":"12","author":"Pfeiffer","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.mam.2023.101218_bib81","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0119703","article-title":"Genetic association of SNPs near ATOH7, CARD10, CDKN2B, CDC7 and SIX1\/SIX6 with the endophenotypes of primary open angle glaucoma in Indian population","volume":"10","author":"Philomenadin","year":"2015","journal-title":"PLoS One"},{"issue":"Pt 3B","key":"10.1016\/j.mam.2023.101218_bib82","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/eye.2000.137","article-title":"Regulation of TIGR\/MYOC gene expression in human trabecular meshwork cells","volume":"14","author":"Polansky","year":"2000","journal-title":"Eye"},{"issue":"7","key":"10.1016\/j.mam.2023.101218_bib83","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.ophtha.2019.12.025","article-title":"An intraocular pressure polygenic risk score stratifies multiple primary open-angle glaucoma parameters including treatment intensity","volume":"127","author":"Qassim","year":"2020","journal-title":"Ophthalmol. Times"},{"key":"10.1016\/j.mam.2023.101218_bib84","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.3390\/jcm10112227","article-title":"miRNAs and genes involved in the interplay between ocular hypertension and primary open-angle glaucoma. Oxidative stress, inflammation, and apoptosis networks","volume":"10","author":"Raga-Cervera","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.mam.2023.101218_bib85","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1126\/science.1066901","article-title":"Adult-onset primary open-angle glaucoma caused by mutations in optineurin","volume":"295","author":"Rezaie","year":"2002","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.mam.2023.101218_bib86","doi-asserted-by":"crossref","first-page":"4494","DOI":"10.3390\/ijms22094494","article-title":"The potential role of small-molecule PERK inhibitor LDN-0060609 in primary open-angle glaucoma treatment","volume":"22","author":"Rozp\u0119dek-Kami\u0144ska","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.mam.2023.101218_bib87","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.3390\/ijms21114171","article-title":"The genetic and endoplasmic reticulum-mediated molecular mechanisms of primary open-angle glaucoma","volume":"21","author":"Rozp\u0119dek-Kami\u0144ska","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.mam.2023.101218_bib88","first-page":"31","article-title":"Genetics of primary open-angle glaucoma and its endophenotypes","volume":"256","author":"Sakurada","year":"2020","journal-title":"Prog. Brain Res."},{"issue":"4","key":"10.1016\/j.mam.2023.101218_bib89","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1136\/bjophthalmol-2013-304267","article-title":"Association between genetic polymorphisms of the prostaglandin F2\u03b1 receptor gene, and response to latanoprost in patients with glaucoma and ocular hypertension","volume":"98","author":"Sakurai","year":"2014","journal-title":"Br. J. Ophthalmol."},{"issue":"6","key":"10.1016\/j.mam.2023.101218_bib90","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.ophtha.2007.03.025","article-title":"Association between genetic polymorphisms of the prostaglandin F2alpha receptor gene and response to latanoprost","volume":"114","author":"Sakurai","year":"2007","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.mam.2023.101218_bib91","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/ICU.0000000000000736","article-title":"Pseudoexfoliation syndrome and glaucoma: from genes to disease mechanisms","volume":"32","author":"Schl\u00f6tzer-Schrehardt","year":"2021","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.mam.2023.101218_bib92","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1089\/jop.2017.0125","article-title":"iDrugs and iDevices discovery and development- preclinical assays, techniques and animal model studies for ocular hypotensives and neuroprotectants","volume":"34","author":"Sharif","year":"2018","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"issue":"3","key":"10.1016\/j.mam.2023.101218_bib93","first-page":"22","article-title":"Ocular hypertension and glaucoma: a review and current perspectives","volume":"2","author":"Sharif","year":"2017","journal-title":"Internet J. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.mam.2023.101218_bib94","first-page":"6","article-title":"Pathogenesis of elevated intraocular pressure and glaucoma-related retinal and optic nerve degeneration: diverse mitigation strategies and treatment modalities","volume":"13","author":"Sharif","year":"2022","journal-title":"EC Ophthalmol."},{"key":"10.1016\/j.mam.2023.101218_bib95","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.4103\/1673-5374.235017","article-title":"Glaucomatous optic neuropathy treatment options: the promise of novel therapeutics, techniques and tools to help preserve vision","volume":"13","author":"Sharif","year":"2018","journal-title":"Neural. Regen. Res."},{"issue":"6","key":"10.1016\/j.mam.2023.101218_bib96","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1021\/acsptsci.0c00137","article-title":"Discovery to launch of anti-allergy (Emadine; Patanol\/Pataday\/Pazeo) and anti-glaucoma (Travatan; Simbrinza) ocular drugs, and generation of novel pharmacological tools such as AL-8810","volume":"3","author":"Sharif","year":"2020","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.mam.2023.101218_bib97","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.729249","article-title":"Therapeutic drugs and devices for tackling ocular hypertension and glaucoma, and need for neuroprotection and cytoprotective therapies","volume":"12","author":"Sharif","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.mam.2023.101218_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.crneur.2022.100037","article-title":"Degeneration of retina-brain components and connections in glaucoma: disease causation and treatment options for eyesight preservation","volume":"3","author":"Sharif","year":"2022","journal-title":"Curr. Res. Neurobiol."},{"issue":"6","key":"10.1016\/j.mam.2023.101218_bib99","doi-asserted-by":"crossref","first-page":"791","DOI":"10.3390\/ph16060791","article-title":"Recently approved drugs for lowering and controlling intraocular pressure to reduce vision loss in ocular hypertensive and glaucoma patients","volume":"16","author":"Sharif","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.mam.2023.101218_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2023.109444","article-title":"Identifying new drugs and targets to treat rapidly elevated intraocular pressure for angle closure and secondary glaucomas to curb visual impairment and prevent blindness","volume":"232","author":"Sharif","year":"2023","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.mam.2023.101218_bib101","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1089\/jop.2022.0046","article-title":"Electrical, electromagnetic, ultrasound wave therapies and electronic implants for neuronal rejuvenation, neuroprotection, axonal regeneration and IOP reduction","volume":"39","author":"Sharif","year":"2023","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"key":"10.1016\/j.mam.2023.101218_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2023.109415","article-title":"FP and EP2 prostanoid receptor agonist drugs and aqueous humor outflow devices for treating ocular hypertension and glaucoma","volume":"229","author":"Sharif","year":"2023","journal-title":"Exp. Eye Res."},{"issue":"8","key":"10.1016\/j.mam.2023.101218_bib103","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1093\/hmg\/ddy053","article-title":"Genome-wide association study identifies seven novel susceptibility loci for primary open-angle glaucoma","volume":"27","author":"Shiga","year":"2018","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/j.mam.2023.101218_bib104","article-title":"Genes and genetics in eye diseases: a genomic medicine approach for investigating hereditary and inflammatory ocular disorders","volume":"11","author":"Singh","year":"2018","journal-title":"Int. J. Ophthalmol."},{"issue":"44","key":"10.1016\/j.mam.2023.101218_bib105","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abq1081","article-title":"Astrocytic dysfunction induced by ABCA1 deficiency causes optic neuropathy","volume":"8","author":"Shinozaki","year":"2022","journal-title":"Sci. Adv."},{"issue":"3","key":"10.1016\/j.mam.2023.101218_bib106","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1001\/jamaophthalmol.2019.5961","article-title":"Genetic heritability of pigmentary glaucoma and associations with other eye phenotypes","volume":"138","author":"Simcoe","year":"2019","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"10.1016\/j.mam.2023.101218_bib107","article-title":"Genes and genetics in eye diseases: a genomic medicine approach for investigating hereditary and inflammatory ocular disorders","volume":"11","author":"Singh","year":"2018","journal-title":"Int. J. Ophthalmol."},{"issue":"8","key":"10.1016\/j.mam.2023.101218_bib108","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a017269","article-title":"The complex role of neuroinflammation in glaucoma","volume":"4","author":"Soto","year":"2014","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"5300","key":"10.1016\/j.mam.2023.101218_bib109","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1126\/science.275.5300.668","article-title":"Identification of a gene that causes primary open angle glaucoma","volume":"275","author":"Stone","year":"1997","journal-title":"Science"},{"issue":"15","key":"10.1016\/j.mam.2023.101218_bib110","doi-asserted-by":"crossref","first-page":"8068","DOI":"10.3390\/ijms23158068","article-title":"Remodeling of the lamina cribrosa: mechanisms and potential therapeutic approaches for glaucoma","volume":"23","author":"Strickland","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.mam.2023.101218_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.104149","article-title":"Long-term and potent IOP-lowering effect of I\u03baB\u03b1-siRNA in a nonhuman primate model of chronic ocular hypertension","volume":"25","author":"Sun","year":"2022","journal-title":"iScience"},{"issue":"2","key":"10.1016\/j.mam.2023.101218_bib112","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1167\/iovs.18-26055","article-title":"Myosin-X silencing in the trabecular meshwork suggests a role for tunneling nanotubes in outflow regulation","volume":"60","author":"Sun","year":"2019","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"48","key":"10.1016\/j.mam.2023.101218_bib113","doi-asserted-by":"crossref","first-page":"40661","DOI":"10.1074\/jbc.M112.384800","article-title":"Glucose-regulated protein 94 triage of mutant myocilin through endoplasmic reticulum-associated degradation subverts a more efficient autophagic clearance mechanism","volume":"287","author":"Suntharalingam","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mam.2023.101218_bib114","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119269","article-title":"Lentiviral vector-mediated expression of C3 transferase attenuates retinal ischemia and reperfusion injury in rats","volume":"272","author":"Tan","year":"2021","journal-title":"Life Sci."},{"issue":"5","key":"10.1016\/j.mam.2023.101218_bib115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1008682","article-title":"Rare protein-altering variants in ANGPTL7 lower intraocular pressure and protect against glaucoma","volume":"16","author":"Tanigawa","year":"2020","journal-title":"PLoS Genet."},{"issue":"13","key":"10.1016\/j.mam.2023.101218_bib116","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1167\/iovs.18-26349","article-title":"Rapid development of glaucoma via ITV nonselective ANGPT 1\/2 antibody: a potential role for ANGPT\/TIE2 signaling in primate aqueous humor outflow","volume":"60","author":"Thackaberry","year":"2019","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.mam.2023.101218_bib117","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","article-title":"Global prevalence of glaucoma and projections of glaucoma burden through 2040","volume":"121","author":"Tham","year":"2014","journal-title":"Ophthalmol. Times"},{"issue":"1","key":"10.1016\/j.mam.2023.101218_bib118","doi-asserted-by":"crossref","first-page":"6072","DOI":"10.1038\/s41467-021-26346-0","article-title":"Cellular crosstalk regulates the aqueous humor outflow pathway and provides new targets for glaucoma therapies","volume":"12","author":"Thomson","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mam.2023.101218_bib119","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/ng.661","article-title":"Common variants near CAV1 and CAV2 are associated with primary open-angle glaucoma","volume":"42","author":"Thorleifsson","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.mam.2023.101218_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101988","article-title":"Nicotinamide provides neuroprotection in glaucoma by protecting against mitochondrial and metabolic dysfunction","volume":"43","author":"Tribble","year":"2021","journal-title":"Redox Biol."},{"issue":"2","key":"10.1016\/j.mam.2023.101218_bib121","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.3892\/mmr.2020.11215","article-title":"Primary open angle glaucoma genetics: the common variants and their clinical associations","volume":"22","author":"Trivli","year":"2020","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.mam.2023.101218_bib122","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.exer.2016.03.017","article-title":"Real-time imaging of RGC death with a cell-impermeable nucleic acid dyeing compound after optic nerve crush in a murine model","volume":"146","author":"Tsuda","year":"2016","journal-title":"Exp. Eye Res."},{"issue":"12","key":"10.1016\/j.mam.2023.101218_bib123","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1038\/s41433-019-0484-1","article-title":"Relationship between intraocular pressure and retinal nerve fibre thickness loss in a monkey model of chronic ocular hypertension","volume":"33","author":"Tu","year":"2019","journal-title":"Eye"},{"issue":"5","key":"10.1016\/j.mam.2023.101218_bib124","doi-asserted-by":"crossref","DOI":"10.1016\/j.ophtha.2014.12.038","article-title":"Association between SNPs of metalloproteinases and prostaglandin F2\u03b1 receptor genes and latanoprost response in open-angle glaucoma","volume":"122","author":"Ussa","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.mam.2023.101218_bib125","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1136\/bjophthalmol-2018-313086","article-title":"SNP located in an AluJb repeat downstream of TMCO1, rs4657473, is protective for POAG in African Americans","volume":"103","author":"Verkuil","year":"2019","journal-title":"Br. J. Ophthalmol."},{"issue":"3\u20134","key":"10.1016\/j.mam.2023.101218_bib126","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41434-021-00281-7","article-title":"XIAP gene therapy effects on retinal ganglion cell structure and function in a mouse model of glaucoma","volume":"29","author":"Visuvanathan","year":"2022","journal-title":"Gene Ther."},{"key":"10.1016\/j.mam.2023.101218_bib127","first-page":"1640","article-title":"Identification of a novel mutation in the NTF4 gene that causes primary open-angle glaucoma in a Chinese population","volume":"16","author":"Vithana","year":"2010","journal-title":"Mol. Vis."},{"key":"10.1016\/j.mam.2023.101218_bib128","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.2014.3192","article-title":"The pathophysiology and treatment of glaucoma: a review","volume":"311","author":"Weinreb","year":"2014","journal-title":"J. Am. Med. Assoc."},{"issue":"6326","key":"10.1016\/j.mam.2023.101218_bib129","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1126\/science.aal0092","article-title":"Vitamin B3 modulates mitochondrial vulnerability and prevents glaucoma in aged mice","volume":"355","author":"Williams","year":"2017","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.mam.2023.101218_bib130","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.ymthe.2019.12.012","article-title":"Gene therapy for glaucoma by ciliary body aquaporin 1 disruption using CRISPR-Cas9","volume":"28","author":"Wu","year":"2020","journal-title":"Mol. Ther."},{"issue":"6","key":"10.1016\/j.mam.2023.101218_bib131","doi-asserted-by":"crossref","first-page":"312","DOI":"10.21037\/atm-22-136","article-title":"Acteoside protects retinal ganglion cells from experimental glaucoma by activating the PI3K\/AKT signaling pathway via caveolin 1 upregulation","volume":"10","author":"Xi","year":"2022","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.mam.2023.101218_bib132","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1080\/13816810.2019.1627465","article-title":"Association of polymorphism rs11656696 in GAS7 with primary open-angle glaucoma in a Chinese population","volume":"40","author":"Xu","year":"2019","journal-title":"Ophthalmic Genet."},{"key":"10.1016\/j.mam.2023.101218_bib133","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2019.107795","article-title":"Update on the genetics of primary open-angle glaucoma","volume":"188","author":"Youngblood","year":"2019","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.mam.2023.101218_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.113797","article-title":"The kinase inhibitor BX795 suppresses the inflammatory response via multiple kinases","volume":"174","author":"Yu","year":"2020","journal-title":"Biochem. Pharmacol."},{"issue":"12","key":"10.1016\/j.mam.2023.101218_bib135","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.3109\/02713683.2016.1143013","article-title":"PTGFR and SLCO2A1 gene polymorphisms determine intraocular pressure response to latanoprost in Han Chinese patients with glaucoma","volume":"41","author":"Zhang","year":"2016","journal-title":"Curr. Eye Res."},{"issue":"12","key":"10.1016\/j.mam.2023.101218_bib136","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1089\/hum.2019.056","article-title":"Silencing of GAS5 alleviates glaucoma in rat models by reducing retinal ganglion cell apoptosis","volume":"30","author":"Zhou","year":"2019","journal-title":"Hum. Gene Ther."},{"issue":"3","key":"10.1016\/j.mam.2023.101218_bib137","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1167\/iovs.11-8837","article-title":"Topical ocular sodium 4-phenylbutyrate rescues glaucoma in a myocilin mouse model of primary open-angle glaucoma","volume":"53","author":"Zode","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."}],"container-title":["Molecular Aspects of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0098299723000584?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0098299723000584?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T20:28:13Z","timestamp":1789676893000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0098299723000584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":137,"alternative-id":["S0098299723000584"],"URL":"https:\/\/doi.org\/10.1016\/j.mam.2023.101218","relation":{},"ISSN":["0098-2997"],"issn-type":[{"value":"0098-2997","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gene therapies and gene product-based drug candidates for normalizing and preserving tissue functions in animal models of ocular hypertension and glaucoma","name":"articletitle","label":"Article Title"},{"value":"Molecular Aspects of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mam.2023.101218","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101218"}}